Although CIP typically emerges within 2 to 3 months following initiation of anti–PD-1 or PD-L1 therapy, the time to onset can vary substantially, from as early as several days to as late as two years (4, 5). Here, CD274 is linked to hereditary sensory and autonomic neuropathy.